Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families

Rodan, 1981, Role of osteoblasts in hormonal control of bone resorption — a hypothesis., Calcif Tissue Int, 33, 349, 10.1007/BF02409454

Chambers, 1992, Regulation of osteoclast development and function In: Rifkin BR, Gay CV (eds) Biology and Physiology of the Osteoclast, CRC Press, Boca Raton, FL, pp, 105

Roodman, 1996, Advances in bone biology: the osteoclast., Endocr Rev, 17, 308

Athanasou, 1996, Cellular biology of bone-resorbing cells., J Bone Joint Surg Am, 78, 1096, 10.2106/00004623-199607000-00016

Suda, 1992, Modulation of osteoclast differentiation., Endocr Rev, 13, 66

Suda, 1996, Osteoclast generation, In: Raisz LG, Rodan GA, Bilezikian JP (eds) Principles of Bone Biology, Academic Press, San Diego, CA, pp, 87

Martin, 1994, Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity., J Cell Biochem, 56, 357, 10.1002/jcb.240560312

Martin, 1998, Hormonal regulation of osteoclast function., Trends Endocrinol Metab, 9, 6, 10.1016/S1043-2760(98)00005-8

Martin, 1998, Interleukins in the control of osteoclast differentiation., Crit Rev Eukaryot Gene Expr, 8, 107, 10.1615/CritRevEukarGeneExpr.v8.i2.10

Udagawa, 1989, The bone marrow-derived stromal cell lines MC3T3–G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells., Endocrinology, 125, 1805, 10.1210/endo-125-4-1805

Yoshida, 1990, The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene., Nature, 345, 442, 10.1038/345442a0

Wiktor-Jedrzejczak, 1990, Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse., Proc Natl Acad Sci USA, 87, 4828, 10.1073/pnas.87.12.4828

Felix, 1990, Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse., Endocrinology, 127, 2592, 10.1210/endo-127-5-2592

Kodama, 1991, Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor., J Exp Med, 173, 269, 10.1084/jem.173.1.269

Takahashi, 1991, Deficiency of osteoclasts in osteopetrotic mice is due to a defect in the local microenvironment provided by osteoblastic cells., Endocrinology, 128, 1792, 10.1210/endo-128-4-1792

Hattersley, 1991, Macrophage colony stimulating factor (M-CSF) is essential for osteoclast formation in vitro., Biochem Biophys Res Commun, 177, 526, 10.1016/0006-291X(91)92015-C

Kodama, 1991, Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells., J Exp Med, 173, 1291, 10.1084/jem.173.5.1291

Udagawa, 1990, Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells., Proc Natl Acad Sci USA, 87, 7260, 10.1073/pnas.87.18.7260

Chambers, 1993, Generation of osteoclast-inductive and osteoclastogenic cell lines from the H-2KbtsA58 transgenic mouse., Proc Natl Acad Sci USA, 90, 5578, 10.1073/pnas.90.12.5578

Miyamoto, 1998, Establishment and characterization of an immortal macrophage-like cell line inducible to differentiate to osteoclasts., Biochem Biophys Res Commun, 242, 703, 10.1006/bbrc.1997.8046

Kurihara, 1990, Identification of committed mononuclear precursors for osteoclast-like cells formed in long-term marrow cultures., Endocrinology, 126, 2733, 10.1210/endo-126-5-2733

Hattersley, 1991, Generation of osteoclast precursors in multilineage hemopoietic colonies., Endocrinology, 128, 259, 10.1210/endo-128-1-259

Wang, 1992, Bone and haematopoietic defects in mice lacking c-fos., Nature, 360, 741, 10.1038/360741a0

Johnson, 1992, Pleiotropic effects of a null mutation in the c-fos proto-oncogene., Cell, 71, 577, 10.1016/0092-8674(92)90592-Z

Grigoriadis, 1994, c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling., Science, 266, 443, 10.1126/science.7939685

Tondravi, 1997, Osteopetrosis in mice lacking haematopoietic transcription factor PU.1., Nature, 386, 81, 10.1038/386081a0

Amizuka, 1997, An ultrastructural study of cell-cell contact between mouse spleen cells and calvaria-derived osteoblastic cells in a co-culture system for osteoclast formation., Acta Histochem Cytochem, 30, 351, 10.1267/ahc.30.351

Kishimoto, 1994, Cytokine signal transduction., Cell, 76, 253, 10.1016/0092-8674(94)90333-6

Tamura, 1993, Soluble interleukin-6 receptor triggers osteoclast formation by interleukin-6., Proc Natl Acad Sci USA, 90, 11924, 10.1073/pnas.90.24.11924

Girasole, 1994, Interleukin-11: a new cytokine critical for osteoclast development., J Clin Invest, 93, 1516, 10.1172/JCI117130

Romas, 1996, The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures., J Exp Med, 183, 2581, 10.1084/jem.183.6.2581

Udagawa, 1995, Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors., J Exp Med, 182, 1461, 10.1084/jem.182.5.1461

Matsuzaki, 1998, Human osteoclast-like cells are formed from peripheral blood mononuclear cells in a co-culture with SaOS-2 cells transfected with the PTH/PTHrP receptor gene., Endocrinology, 140, 925, 10.1210/endo.140.2.6573

Liu, 1998, Conditionally immortalized murine bone marrow stromal cells mediate parathyroid hormone-dependent osteoclastogenesis in vitro., Endocrinology, 139, 1952, 10.1210/endo.139.4.5895

Yoshizawa, 1997, Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning., Nat Genet, 16, 391, 10.1038/ng0897-391

Takeda, Endocrinology, 140, 1005, 10.1210/endo.140.2.6673

Akatsu, 1992, Preparation and characterization of a mouse osteoclast-like multinucleated cell population., J Bone Miner Res, 7, 1297, 10.1002/jbmr.5650071109

Tamura, 1993, A new resorption assay with mouse osteoclast-like multinucleated cells formed in vitro., J Bone Miner Res, 8, 953, 10.1002/jbmr.5650080808

Suda, 1997, Role of 1α,25-dihydroxyvitamin D3 in osteoclast differentiation and function., Methods Enzymol, 282, 223, 10.1016/S0076-6879(97)82110-6

Jimi, 1996, Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact., Endocrinology, 137, 2187, 10.1210/endo.137.5.8612568

Suda, 1997, Regulation of osteoclast function., J Bone Miner Res, 12, 869, 10.1359/jbmr.1997.12.6.869

Wesolowski, 1995, Isolation and characterization of highly enriched, prefusion mouse osteoclastic cells., Exp Cell Res, 219, 679, 10.1006/excr.1995.1279

Simonet, 1997, Osteoprotegerin: a novel secreted protein involved in the regulation of bone density., Cell, 89, 309, 10.1016/S0092-8674(00)80209-3

Tsuda, 1997, Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis., Biochem Biophys Res Commun, 234, 137, 10.1006/bbrc.1997.6603

Yasuda, 1998, Identification of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG inhibits osteoclastogenesis in vitro., Endocrinology, 139, 1329, 10.1210/endo.139.3.5837

Tomoyasu, 1998, Characterization of monomeric and homodimeric forms of osteoclastogenesis inhibitory factor., Biochem Biophys Res Commun, 245, 382, 10.1006/bbrc.1998.8443

Yamamoto, 1998, Hypocalcemic effect of osteoclastogenesis inhibitory factor/osteoprotegerin in the thyroparathyroidectomized rat., Endocrinology, 139, 4012, 10.1210/endo.139.9.6290

Akatsu, 1998, Osteoclastogenesis inhibitory factor (OCIF) exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy., Bone, 23, 495, 10.1016/S8756-3282(98)00141-0

Tan, 1997, Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells., Gene, 204, 35, 10.1016/S0378-1119(97)00509-X

Kwon, 1998, TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption., FASEB J, 12, 845, 10.1096/fasebj.12.10.845

Smith, 1994, The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death., Cell, 76, 959, 10.1016/0092-8674(94)90372-7

Yamaguchi, 1998, Characterization of structural domains of human osteoclastogenesis inhibitory factor., J Biol Chem, 273, 5117, 10.1074/jbc.273.9.5117

Mizuno, 1998, Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin., Biochem Biophys Res Commun, 237, 610, 10.1006/bbrc.1998.8697

Bucay, 1998, Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification., Genes Dev, 12, 1260, 10.1101/gad.12.9.1260

Emery, 1998, Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL., J Biol Chem, 273, 14363, 10.1074/jbc.273.23.14363

Yasuda, 1998, Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL., Proc Natl Acad Sci USA, 95, 3597, 10.1073/pnas.95.7.3597

Tsukii, 1998, Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1α,25-dihydroxyvitamin D3, prostaglandin E2 or parathyroid hormone in the microenvironment of bone., Biochem Biophys Res Commun, 246, 337, 10.1006/bbrc.1998.8610

Lacey, 1998, Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation., Cell, 93, 165, 10.1016/S0092-8674(00)81569-X

Kong, Nature, 397, 315, 10.1038/16852

Wong, 1997, TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells., J Biol Chem, 272, 25190, 10.1074/jbc.272.40.25190

Wong, 1997, TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor., J Exp Med, 12, 2075, 10.1084/jem.186.12.2075

Anderson, 1997, A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function., Nature, 390, 175, 10.1038/36593

Darnay, 1998, Characterization of the intracellular domain of receptor activator of NF-κB (RANK)., J Biol Chem, 273, 20551, 10.1074/jbc.273.32.20551

Wong, 1998, The TRAF family of signal transducers mediates NF-κB activation by the TRANCE receptor., J Biol Chem, 273, 28355, 10.1074/jbc.273.43.28355

Tanaka, 1993, Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors., J Clin Invest, 91, 257, 10.1172/JCI116179

Biskobing, 1995, Characterization of M-CSF-induced proliferation and subsequent osteoclast formation in murine marrow culture., J Bone Miner Res, 10, 1025, 10.1002/jbmr.5650100706

Tsurukai, 1998, Isolation and characterization of osteoclast precursors that differentiate into osteoclasts on calvarial cells within a short period of time., J Cell Physiol, 177, 26, 10.1002/(SICI)1097-4652(199810)177:1<26::AID-JCP3>3.0.CO;2-G

Tsurukai, 1998

Jimi, 1995, Macrophage colony-stimulating factor and interleukin 1α maintain the survival of osteoclast-like cells., Endocrinology, 136, 808, 10.1210/endo.136.2.7835314

Jimi, 1996, Interleukin-1α activates an NF-κB-like factor in osteoclast-like cells., J Biol Chem, 271, 4605, 10.1074/jbc.271.9.4605

Jimi, 1998, Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells., Exp Cell Res, 247, 84, 10.1006/excr.1998.4320

Jimi, 1999

Udagawa, 1998

Fuller, 1998, TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts., J Exp Med, 188, 997, 10.1084/jem.188.5.997

Jimi, 1998, Activation of NF-κB is involved in the survival of osteoclasts promoted by interleukin-1., J Biol Chem, 273, 8799, 10.1074/jbc.273.15.8799

Franzoso, 1997, Requirement for NF-κB in osteoclast and B-cell development., Genes Dev, 11, 3482, 10.1101/gad.11.24.3482

Iotsova, 1997, Osteopetrosis in mice lacking NF-κB1 and NF-κB2., Nat Med, 3, 1285, 10.1038/nm1197-1285

Fujikawa, 1996, The human osteoclast precursor circulates in the monocyte fraction., Endocrinology, 137, 4058, 10.1210/endo.137.9.8756585

Sarma, 1996, Macrophage colony-stimulating factor induces substantial osteoclast generation and bone resorption in human bone marrow cultures., Blood, 88, 2531, 10.1182/blood.V88.7.2531.bloodjournal8872531

Sarma, 1998, Inhibition of bone resorption by 17β-estradiol in human bone marrow cultures., J Cell Physiol, 175, 99, 10.1002/(SICI)1097-4652(199804)175:1<99::AID-JCP11>3.0.CO;2-J

Matsuzaki, 1998, Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures., Biochem Biophys Res Commun, 246, 199, 10.1006/bbrc.1998.8586

Matsuzaki, 1998

Quinn, 1998, A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro., Endocrinology, 139, 4424, 10.1210/endo.139.10.6331